FibroGen, Inc. (NASDAQ:FGEN) Receives Consensus Recommendation of “Reduce” from Brokerages
Shares of FibroGen, Inc. (NASDAQ:FGEN – Get Free Report) have been assigned a consensus recommendation of “Reduce” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation and four have assigned a hold recommendation to the company. The average 12-month target […]
More Stories
Labor Department Reverses Biden-Era Stance on Crypto in 401(k) Plans
By Chase Smith The U.S. Department of Labor on May 28 rescinded 2022 guidance that warned fiduciaries against including cryptocurrency...
Rubio Announces Visa Restrictions on Foreign Nationals Involved in Censoring Americans
By Ryan Morgan Secretary of State Marco Rubio announced on May 28 new visa restrictions against foreign nationals involved in...
What Newly Released UFO Reports by Civilian Pilots Reveal
By Jacob Burg A pilot flying near Ronald Reagan Washington National Airport reported seeing an “unknown phenomenon” strobing and moving...
Top 10 Richest Musicians of United States
Music isn’t just an art— its a multi-billion dollar industry where successful artists turn into Global Superstars. There are artists...
Goodbye SIM Cards: Apple’s E-Sim Feature set to launch on the Latest Android Version
The battle between the two famed competitors just got a little interesting. A recent leak of Android signifies a collaboration...
US-China Tariff Truce Triggers Cargo Stampede, Scramble to Diversify Beyond China: Analysts
By Sean Tseng When word broke on May 12 that Washington and Beijing had agreed to a 90-day tariff pause,...